Abstract
is evaluated at the Commission level by a scientific committee, presently called the 23
Scientific Committee on Consumer Safety (SCCS). 24
According to the Cosmetics Regulations, in the EU, the marketing of cosmetics 25 products and their ingredients that have been tested on animals for most of their 26 human health effects, including acute toxicity, is prohibited. Nevertheless, any study 27 dating from before this prohibition took effect is accepted for the safety assessment of 28 cosmetics ingredients. The in vitro methods reported in the dossiers summited to the 29 SCCS are here evaluated from the published reports issued by the scientific committee 30 of the Directorate General of Health and Consumers (DG SANCO); responsible for the 31 safety of cosmetics ingredients. The number of studies submitted to the SCCS that do 32 not involve animals is still low and in general the safety of cosmetics ingredients is 33 based on in vivo studies performed before the prohibition. Acute toxicity 167
Studies of acute toxicity are not always necessary for the dossiers summited to the 168 SCCS, but they are usually included in those supplied by industrial sources and in all 169 cases the studies were performed on laboratory animals. The oral route was the most 170 common, but the dermal route was also used occasionallyand in a few cases 171 information about the inhalation route was also supplied. All the accepted methods for 172 determining acute oral toxicity are based on in vivo experiments that estimate the LD50 173 value (i.e., the single dose of a substance that can be expected to cause death in 50% 174 of the animals in an experimental group). Considering the prohibition on the use of 175 animals for cosmetics ingredients and building on the results of a previous international 176 validation study, a follow-up study was organised by the ECVAM to assess whether the 177 3T3 Neutral Red Uptake cytotoxicity assay could identify substances not requiring 178 classification as acute oral toxicants under the EU regulations. The assay exhibited 179 high sensitivity (92%-96%) but relatively low specificity (40%-44%). It could thus prove 180 to be a valuable part of an integrated testing strategy: a read-across argument or 181 weight-of-evidence (WoE) approach to identifying non-toxic chemicals (LD50 > 2000 182 mg/kg) (Prieto et al., 2013 
Eye irritation 189
Eye irritation is one of the classic studies performed on animals, usually rabbits, as 190 reported many years ago (Draize et al., 1944) . The method has been highly 191 controversial and much effort has gone into developing alternative methods (Vinardell 192 and Mitjans, 2008). However, the validated in vitro methods focus on distinguishing 193 corrosive and more irritant chemicals from non-irritants, and they do not make 194 categorisation possible, in contrast to the in vivo method. In the dossiers submitted to 195 the SCCS, nearly all the studies were performed on albino rabbits; only a few used in 196 vitro methods. The majority of the in vivo studies performed on rabbits followed the 197 OECD guidelines, which were adopted in 1981 and updated successively in 1987, Harmonised System for the Classification and Labelling of Chemicals (GHS)); or 2) not 207 requiring classification for eye irritation or serious eye damage according to the GHS. 208
Other methods that are used include the Het-Cam: a method that has not been 209 validated but which is very widely used by the cosmetics industry due to its low cost; 210 and neutral red uptake in cell cultures (Spielmann et al., 1996) . When comparing the 211 results for hair dyes with those for other ingredients, we observed that in the former 212 case there were no studies on human volunteers whereas in the latter case human 213 studies represented 9% of the total. When we considered all the ingredients together, 214 the percentage of human studies was just 3% (Figure 1 former, allows for confidence in the outcomes of these assays, such that in-house 291 safety assessments of new products can be made without the use of animal testing. A 292 decision tree for hazard assessment and classification, using a WoE approach 293 throughout, involves stepwise evaluation of: firstly, physicochemical characteristics, 294 (Q)SAR and existing data, to identify and rule out corrosive chemicals from further 295 testing; secondly, in vitro corrosivity; and finally, in vitro irritation, to distinguish between 296 irritants and non-irritants. Once a chemical has been classified as corrosive, irritant or 297 non-irritant, its safety assessment can then be evaluated using a second decision tree 298 approach. Corrosive chemicals should be tested in an in vitro corrosivity test at the use 299 concentration and, if shown to be non-corrosive, tested for irritation using an RHE in 300 vitro irritation model. Chemicals classed as irritants can be retested at the usage 301 concentration, since they may not be irritants at lower concentrations or when used in 302 the final formulation. Human confirmatory testing of the formulation is only carried out 303 on a case-by-case basis. In conclusion, the evaluation of the skin irritation potential of 304 new chemicals to be used in cosmetics can be confidently accomplished using only 305 alternative methods (Macfarlane et al., 2009) . 306 307 3.4.
Skin sensitisation 308
For skin sensitisation, the studies were mostly performed in vivo (81%) and a small 309 percentage on humans using the patch test method (Figure 3) . The LLNA is considered a reduction and refinement method compared to the traditional 345 guinea pig tests since it provides advantages in terms of animal welfare, but it cannot 346 more be used for evaluation of ingredients in cosmetics. 347
The most commonly used in vivo method was the LLNA. The basic principle underlying 348 the mouse LLNA is that sensitisers induce a primary proliferation of lymphocytes in the 349 auricular lymph nodes that drain the chemical application site. This proliferation is 350
proportional to the dose applied and provides a measure of sensitisation. The human studies were performed by old methods (Marzulli and Maibach, 1986 ; 365 Kligman, 1966; Kligman and Epstein, 1975 ) based on the maximisation response in 366 volunteers. The human repeat insult patch test (HRIPT) consists of 2 phases, or 367 sometimes 3. Phase I is the induction phase, where the product is applied to the skin 9 368 times over the course of 3 weeks. This is followed by a two-week rest period, after 369 which the skin is exposed to the product again in phase II: the elicitation phase. A 370 response in phase II is usually allergic in nature and phase III is used to verify and 371 better define the reaction. The different methods available have different application 372 phases, but the resulting predictions of allergy and irritation response are the scientific 373 goals. Use of the HRIPT is considered unethical by the SCCS. 374 375 3.5.
Dermal absorption 376
Dermal absorption is a well-established in vitro method that is described in the OECD 377 guidelines and there is a special SCCS memorandum that describes the procedure 378 (SCCS/1358/10). Despite the existence of an in vitro protocol, some studies were 379 performed on animals and human volunteers ( Figure 5 ). 380
The in vivo studies were performed on rats, but in some cases rabbits were also used. 381
The in vitro method can use skin from humans or pigs, according to the SCCS 382 recommendations. Human skin is the better choice but is not always readily available. Alternatively, pig skin may be used as it shares essential permeation characteristics 396 with human skin. However, 12 studies (11.65%) used rat skin, despite high levels of 397 absorption having been demonstrated for this skin; it is some 2 to 10 times more 398 permeable than human skin due to differences in the thickness of the epidermis (Ross 399
et al., 2000). 400
Another option is to use cultured or reconstructed human skin models; but such 401 evaluate the assay (Isfort, 1996) . 
Toxicokinetic studies 467
The Toxicokinetic studies included different procedures and were usually performed in 468 vivo on different animals or humans (Fig 7) . 
volunteers. 481 482
In vitro methods to study these phenomena should be based on different aspects of the 483 process (absorption, metabolism, etc.). 484
The process of absorption has been studied in the TC-7 cell line, which is a clone of 485
CaCo-2 cells, usually used in in vitro studies of oral absorption (Gres et al., 1998). In 486 total, 10 hair dyes were studied. A study sponsored by the ECVAM evaluated the 487 reproducibility (between-laboratory and within-laboratory variability) and the predictive 488 Phototoxicity 502 Phototoxicity studies were carried out on products that are especially exposed to solar 503 radiation, such as UV filters, but also on some other products, such as some hair dyes, 504 preservatives, etc. In all, only 35 of the products were studied for phototoxicity. One 505 third of the studies were in vitro and nearly half were in vivo: the rest were on human 506 volunteers (Figure 8) . 2013). It is surprising that so few studies were performed using this method, 529
considering it was the first validated in vitro method to be accepted by the OECD 530
(OECD, 2004). 531
A recent study has established a non-animal photosafety assessment approach for 532 cosmetics using in vitro photochemical and photobiochemical screening systems The 533 photochemical properties were assessed in by UV/VIS spectral analysis, reactive 534 oxygen species (ROS) assay and 3T3 neutral red uptake phototoxicity testing (3T3 535 NRU PT). These in vitro screening systems individually provide false predictions; 536 however, a systematic tiered approach using these assays was proposed to provide 537 photosafety assessment without any false-negatives (Onoue et al. 2013) . 538 539
Conclusions 540
The toxicological studies of new cosmetics ingredients should at present be in vitro. 541
However, safety evaluation can be based on in vivo studies performed before the 542
European ban on the use of animals came into effect. The evaluations of different 543 cosmetics ingredients performed by the SCCS are mostly based on in vivo studies from 544 before the ban. At the moment, the total number of in vitro studies is small compared to 545 that of studies on laboratory animals. We believe the near future will see an increase in 546 the use of in vitro methods. There are some validated and accepted methods, but there 547
are not methods for all the studies required; there are no validated and accepted 548 methods for repeat dose toxicity, toxicokinetics and others. 549 
